Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business Practice

Business & Regulation Business Practice

MAICing a Decision

| James Strachan

Do methods that compare newly approved drugs with those already on the market help cut healthcare costs?

Business & Regulation Business Practice

Brexit: Preparing Is Caring

| James Strachan

Most, but not all, UK pharma companies are on track to keep their medicines on the European market by March, 2019.

Discovery & Development Business Practice

In Conversation with Christophe Le Ret of Umicore Precious Metals Chemistry at CPhI 2017

Here, James speaks with Christophe Le Ret from Umicore.

Discovery & Development Business Practice

In Conversation with Michel Lagarde from Patheon part of Thermo Fisher Scientific at CPhI 2017

Here, James speaks with Michel Lagarde from Thermo Fischer Scientific (Patheon).

Discovery & Development Business Practice

In Conversation with Tony van Bijleveld from Patheon part of Thermo Fisher Scientific at CPhI 2017

Here, James speaks with Tony van Bijleveld from Thermo Fischer Scientific (Patheon).

Business & Regulation Business Practice

The Successful Experiment

Sitting Down With... Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.

Business & Regulation Business Practice

All Eyes on Biopharma Trends

| Stephanie Sutton, Roisin McGuigan

We examine the most commercially important biotherapeutics now, and in the future.

Manufacture Business Practice

Make China Great Again

| James Strachan

China is upping its game with plans to revolutionize its manufacturing industries, including pharma.

Business & Regulation Standards & Regulation

Ireland’s Brexit Trump Card

| Tommy Fanning

Tommy Fanning believes that Ireland’s pharma industry will continue to thrive, despite tax cuts in the US and Brexit.

Business & Regulation Business Practice

In Pharma We (Don’t) Trust

| Roisin McGuigan, Joanna Cummings

Consumer trust in pharma nosedives because of the “blame game.”

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register